Fiche d’information aux médecins : traitement de l’œdème maculaire diabétique

UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Archives of Ophthalmology. ,vol. 127, pp. 245- 251 ,(2009) , 10.1001/ARCHOPHTHALMOL.2008.610

David M. Brown, Quan Dong Nguyen, Dennis M. Marcus, David S. Boyer, Sunil Patel, Leonard Feiner, Patricio G. Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G. Rubio, Anthony P. Adamis, Jason S. Ehrlich, J. Jill Hopkins, Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology. ,vol. 120, pp. 2013- 2022 ,(2013) , 10.1016/J.OPHTHA.2013.02.034

, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. The New England Journal of Medicine. ,vol. 372, pp. 1193- 1203 ,(2015) , 10.1056/NEJMOA1414264

David S Boyer, David Faber, Sunil Gupta, Sunil S Patel, Homayoun Tabandeh, Xiao-Yan Li, Charlie C Liu, Jean Lou, Scott M Whitcup, DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 31, pp. 915- 923 ,(2011) , 10.1097/IAE.0B013E318206D18C

David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup, Ozurdex MEAD Study Group, None, Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema Ophthalmology. ,vol. 121, pp. 1904- 1914 ,(2014) , 10.1016/J.OPHTHA.2014.04.024

Michael J Elman, Allison Ayala, Neil M Bressler, David Browning, Christina J Flaxel, Adam R Glassman, Lee M Jampol, Thomas W Stone, Diabetic Retinopathy Clinical Research Network, None, Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results Ophthalmology. ,vol. 122, pp. 375- 381 ,(2015) , 10.1016/J.OPHTHA.2014.08.047

Michael J Elman, Neil M Bressler, Haijing Qin, Roy W Beck, Frederick L Ferris III, Scott M Friedman, Adam R Glassman, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun, Diabetic Retinopathy Clinical Research Network, Writing Committee, None, Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Ophthalmology. ,vol. 118, pp. 609- 614 ,(2011) , 10.1016/J.OPHTHA.2010.12.033

T. A. Ciulla, A. G. Amador, B. Zinman, Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies Diabetes Care. ,vol. 26, pp. 2653- 2664 ,(2003) , 10.2337/DIACARE.26.9.2653

Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris III, Scott M Friedman, Adam R Glassman, Kellee M Miller, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun, Diabetic Retinopathy Clinical Research Network, None, Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Ophthalmology. ,vol. 117, pp. 1064- ,(2010) , 10.1016/J.OPHTHA.2010.02.031